title: Different effects of low-dose transdermal and oral oestrogen therapy on procarboxy-peptidase U, an inhibitor of fibrinolysis, in healthy postmenopausal women: a randomised, placebo-controlled study.
authors.forename: Marinka S
authors.initials: MS
authors.lastname: Post
authors.forename: Judith R
authors.initials: JR
authors.lastname: Leurs
authors.forename: Marius J
authors.initials: MJ
authors.lastname: van der Mooren
authors.forename: W Marchien
authors.initials: WM
authors.lastname: van Baal
authors.forename: Dirk F
authors.initials: DF
authors.lastname: Hendriks
authors.forename: Coen D A
authors.initials: CD
authors.lastname: Stehouwer
authors.forename: Peter
authors.initials: P
authors.lastname: Kenemans
mesh_terms: D025901:Carboxypeptidase B2 / Q000097:blood*; D004333:Drug Administration Routes; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause
chemical_list: D004958:Estradiol; D025901:Carboxypeptidase B2